Market Research Logo

Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2018

Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2018

Summary


GlobalData's Medical Devices sector report, “Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2018 provides an overview of Injectable Drug Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Injectable Drug Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Injectable Drug Delivery under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Injectable Drug Delivery and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Injectable Drug Delivery under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


GDME0528EPD_Sample.pdf

  • Introduction
    • Injectable Drug Delivery Overview
  • Products under Development
    • Injectable Drug Delivery - Pipeline Products by Stage of Development
      • Table Figure 1: Injectable Drug Delivery - Pipeline Products by Stage of Development
      • Table Injectable Drug Delivery - Pipeline Products by Stage of Development
    • Injectable Drug Delivery - Pipeline Products by Segment
      • Table Figure 2: Injectable Drug Delivery - Pipeline Products by Segment
      • Table Injectable Drug Delivery - Pipeline Products by Segment
    • Injectable Drug Delivery - Pipeline Products by Territory
      • Table Figure 3: Injectable Drug Delivery - Pipeline Products by Territory
      • Table Injectable Drug Delivery - Pipeline Products by Territory
    • Injectable Drug Delivery - Pipeline Products by Regulatory Path
      • Table Figure 4: Injectable Drug Delivery - Pipeline Products by Regulatory Path
      • Table Injectable Drug Delivery - Pipeline Products by Regulatory Path
    • Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
      • Table Injectable Drug Delivery - Pipeline Products by Estimated Approval Date
    • Injectable Drug Delivery - Ongoing Clinical Trials
      • Table Figure 6: Injectable Drug Delivery - Ongoing Clinical Trials
      • Table Injectable Drug Delivery - Ongoing Clinical Trials
  • Injectable Drug Delivery - Pipeline Products under Development by Companies
    • Injectable Drug Delivery Companies - Pipeline Products by Stage of Development
      • Table Injectable Drug Delivery Companies - Pipeline Products by Stage of Development
    • Injectable Drug Delivery - Pipeline Products by Stage of Development
      • Table Injectable Drug Delivery - Pipeline Products by Stage of Development
  • Injectable Drug Delivery Companies and Product Overview
    • 3M Co Company Overview
      • 3M Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3M Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table 3M Hollow Microstructured Transdermal System - Product Status
        • Table 3M Hollow Microstructured Transdermal System - Product Description
    • Adamis Pharmaceuticals Corp Company Overview
      • Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adamis Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Symjepi - Junior Version - Product Status
        • Table Symjepi - Junior Version - Product Description
    • AdrenaCard, Inc. Company Overview
      • AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Adrenacard Auto-Injector - Product Status
        • Table Adrenacard Auto-Injector - Product Description
    • Allergan Inc Company Overview
      • Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Allergan Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NOVADUR Intravitreal Implant - Product Status
        • Table NOVADUR Intravitreal Implant - Product Description
    • Alsensa ApS Company Overview
      • Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview
        • Table SQJCT - Product Status
        • Table SQJCT - Product Description
    • Antares Pharma Inc Company Overview
      • Antares Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Antares Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table QuickShot Testosterone (QST) - Product Status
        • Table QuickShot Testosterone (QST) - Product Description
        • Table Teva Pen 1 - Product Status
        • Table Teva Pen 1 - Product Description
        • Table Vibex EPI - Product Status
        • Table Vibex EPI - Product Description
        • Table Vibex QS M - Product Status
        • Table Vibex QS M - Product Description
    • Aquavit Pharmaceuticals Inc Company Overview
      • Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aquavit Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PITO-001 - Product Status
        • Table PITO-001 - Product Description
    • Artemes Technologies, Inc. Company Overview
      • Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Artemes Magnetic Injection System - Product Status
        • Table Artemes Magnetic Injection System - Product Description
    • Ascendis Pharma A/S Company Overview
      • Ascendis Pharma A/S Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ascendis Pharma A/S Pipeline Products & Ongoing Clinical Trials Overview
        • Table TransCon hGH Auto-Injector - Product Status
        • Table TransCon hGH Auto-Injector - Product Description
        • Table Ascendis Pharma A/S - Ongoing Clinical Trials Overview
        • Table TransCon hGH Auto-Injector - A Multicenter, Phase III, Randomized, Open-label, Active-controlled, Parallel-group Trial Investigating the Safety, Tolerability, and Efficacy of TransCon hGH Administered Once a Week Versus Standard Daily hGH Replacement Therapy Over 52 Weeks in Prepubertal Children with Growth Hormone Deficiency (GHD)
    • Ascil Proyectos SL Company Overview
      • Ascil Proyectos SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ascil Proyectos SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Prefilled Device - Product Status
        • Table Prefilled Device - Product Description
    • ASIS Corp Company Overview
      • ASIS Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table ASIS Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Automatic Subdermal Injection System - Product Status
        • Table Automatic Subdermal Injection System - Product Description
        • Table ASIS Corp - Ongoing Clinical Trials Overview
        • Table Automatic Subdermal Injection System - ASIS for Botox in Chronic Migraine
        • Table Automatic Subdermal Injection System - ASIS for Botox in Upper Limb Spasticity
        • Table Automatic Subdermal Injection System - ASIS for Enbrel in Plaque Psoriasis
    • AstraZeneca Plc Company Overview
      • AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bydureon BCise Autoinjector Device - Product Status
        • Table Bydureon BCise Autoinjector Device - Product Description
    • AzureBio SL Company Overview
      • AzureBio SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table AzureBio SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Needle - Product Status
        • Table Injectable Needle - Product Description
    • Becton Dickinson and Co Company Overview
      • Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
        • Table BD Intevia Disposable Autoinjector - Product Status
        • Table BD Intevia Disposable Autoinjector - Product Description
        • Table BD Libertas Wearable Injector - Product Status
        • Table BD Libertas Wearable Injector - Product Description
        • Table T2 Patch Wearable Injector - Product Status
        • Table T2 Patch Wearable Injector - Product Description
    • BioCorRx Inc Company Overview
      • BioCorRx Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioCorRx Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Naltrexone Implant - BICX101 - Product Status
        • Table Injectable Naltrexone Implant - BICX101 - Product Description
        • Table Naltrexone Implant - BICX102 - Product Status
        • Table Naltrexone Implant - BICX102 - Product Description
    • BioMarin Pharmaceutical Inc Company Overview
      • BioMarin Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMarin Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pegvaliase Pre-filled Syringe - Product Status
        • Table Pegvaliase Pre-filled Syringe - Product Description
    • BioRestorative Therapies Inc Company Overview
      • BioRestorative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioRestorative Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Curved Needle Device - Product Status
        • Table Curved Needle Device - Product Description
    • Bioxis Pharmaceuticals Company Overview
      • Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vaccine Delivery Device - Product Status
        • Table Vaccine Delivery Device - Product Description
    • BTG Plc Company Overview
      • BTG Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BTG Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Varithena - Aesthetic Leg Veins - Product Status
        • Table Varithena - Aesthetic Leg Veins - Product Description
    • Burke Pharmaceuticals LLC Company Overview
      • Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Burke Pharmaceuticals LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table BURKE201 Needle Injection Pen - Product Status
        • Table BURKE201 Needle Injection Pen - Product Description
    • Callisyn Biomedical Inc Company Overview
      • Callisyn Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Callisyn Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table TACEspheres Drug Eluting Embolic Microspheres - Product Status
        • Table TACEspheres Drug Eluting Embolic Microspheres - Product Description
    • Cambridge Consultants Ltd Company Overview
      • Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cambridge Consultants Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flexi-ject - Product Status
        • Table Flexi-ject - Product Description
    • Case Western Reserve University Company Overview
      • Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pressure Driven Local Drug Delivery System - Liver Cancer - Product Status
        • Table Pressure Driven Local Drug Delivery System - Liver Cancer - Product Description
    • Cincinnati Children's Hospital Medical Center Company Overview
      • Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pre-Filled Syringe With Flush - Product Status
        • Table Pre-Filled Syringe With Flush - Product Description
    • Clearside BioMedical Inc Company Overview
      • Clearside BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Clearside BioMedical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SCS Microinjector - Product Status
        • Table SCS Microinjector - Product Description
        • Table Clearside BioMedical Inc - Ongoing Clinical Trials Overview
        • Table SCS Microinjector - A Phase III, Randomized, Masked, Controlled Clinical Trial to Study the Safety and Efficacy of Triamcinolone Acetonide Injectable Suspension (CLS-TA) for the Treatment of Subjects with Macular Edema Associated with Non-infectious Uveitis
        • Table SCS Microinjector - A Randomized, Masked, Controlled Trial to Study the Safety and Efficacy of Suprachoroidal CLS-TA in Conjunction with Intravitreal Aflibercept in Subjects with Retinal Vein Occlusion: SAPPHIRE
        • Table SCS Microinjector - Multi-center, Non-interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated with Non-infectious Uveitis
        • Table SCS Microinjector - Phase I/II Study of CLS-1002 for Wet Age-related Macular Degeneration (AMD)
    • Consort Medical plc Company Overview
      • Consort Medical plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Consort Medical plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ASI Auto-Injector - Product Status
        • Table ASI Auto-Injector - Product Description
        • Table INJ200 Autoinjector - Product Status
        • Table INJ200 Autoinjector - Product Description
        • Table Lila Mix Injector - Product Status
        • Table Lila Mix Injector - Product Description
        • Table SYR075 - Product Status
        • Table SYR075 - Product Description
    • DALI Medical Devices Ltd. Company Overview
      • DALI Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table DALI Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table SAN-L - Product Status
        • Table SAN-L - Product Description
        • Table SAN-Light Premium Safety Needle - Product Status
        • Table SAN-Light Premium Safety Needle - Product Description
        • Table SAN-P - Product Status
        • Table SAN-P - Product Description
    • Delcath Systems Inc Company Overview
      • Delcath Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Delcath Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hepatic CHEMOSAT Delivery System - Product Status
        • Table Hepatic CHEMOSAT Delivery System - Product Description
        • Table Delcath Systems Inc - Ongoing Clinical Trials Overview
        • Table Hepatic CHEMOSAT Delivery System - A Randomized, Controlled, Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-dominant Ocular Melanoma
        • Table Hepatic CHEMOSAT Delivery System - Collection of Safety, Efficacy and Resource Utilization Information in Patients Who Have Received Melphalan PHP with the Delcath Hepatic Delivery System for the Treatment of Unresectable Hepatic Malignancy
        • Table Hepatic CHEMOSAT Delivery System - Randomized, Controlled Study to Compare the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment Given Sequentially Following Cisplatin/Gemcitabine Versus Cisplatin/Gemcitabine in Patients with IntraHepatic Cholangiocarcinoma
    • DelSite, Inc. (Inactive) Company Overview
      • DelSite, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table DelSite, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table GelSure - Product Status
        • Table GelSure - Product Description
    • Elcam Medical Company Overview
      • Elcam Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Elcam Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flexi-Q eMU-C - Product Status
        • Table Flexi-Q eMU-C - Product Description
        • Table Flexi-Q eMU-P - Product Status
        • Table Flexi-Q eMU-P - Product Description
        • Table Flexi-Q HV - Product Status
        • Table Flexi-Q HV - Product Description
        • Table Flexi-Q mMU - Product Status
        • Table Flexi-Q mMU - Product Description
        • Table Flexi-Q PFS - Product Status
        • Table Flexi-Q PFS - Product Description
        • Table Patch Pump - Product Status
        • Table Patch Pump - Product Description
    • EmboMedics Inc Company Overview
      • EmboMedics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EmboMedics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table EmboMedics Microspheres - Product Status
        • Table EmboMedics Microspheres - Product Description
        • Table Second Generation Injectable Microsphere - Product Status
        • Table Second Generation Injectable Microsphere - Product Description
    • Emergent BioSolutions Inc Company Overview
      • Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Emergent BioSolutions Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table D4 Auto Injector - Product Status
        • Table D4 Auto Injector - Product Description
        • Table Emergard - Product Status
        • Table Emergard - Product Description
        • Table PC2A Auto-Injector - Product Status
        • Table PC2A Auto-Injector - Product Description
        • Table Trobigard - Product Status
        • Table Trobigard - Product Description
    • Eveon SAS Company Overview
      • Eveon SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eveon SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Automated Injection Device - Product Status
        • Table Automated Injection Device - Product Description
        • Table Intuity Ject - Product Status
        • Table Intuity Ject - Product Description
    • FHC Inc Company Overview
      • FHC Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table FHC Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intracerebral Microinjection Instrument - Product Status
        • Table Intracerebral Microinjection Instrument - Product Description
    • GeneSYS-ID Inc Company Overview
      • GeneSYS-ID Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GeneSYS-ID Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rx MyDOSE - Product Status
        • Table Rx MyDOSE - Product Description
    • Ghent University Company Overview
      • Ghent University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ghent University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Poly-electrolyte Micropartcle (PEM) System - Product Status
        • Table Poly-electrolyte Micropartcle (PEM) System - Product Description
    • Inovio Pharmaceuticals Inc Company Overview
      • Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inovio Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iject Pre-Filled Syringe - Product Status
        • Table Iject Pre-Filled Syringe - Product Description
        • Table Jupiter Jet - Product Status
        • Table Jupiter Jet - Product Description
    • InVivo Therapeutics Corp Company Overview
      • InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table TrailMaker - Product Status
        • Table TrailMaker - Product Description
    • Ipsen SA Company Overview
      • Ipsen SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ipsen SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table 4-In-1 Device - Product Status
        • Table 4-In-1 Device - Product Description
    • kaleo Inc Company Overview
      • kaleo Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table kaleo Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AUVI-Q - Infants And Children - Product Status
        • Table AUVI-Q - Infants And Children - Product Description
    • LyoGo Company Overview
      • LyoGo Pipeline Products & Ongoing Clinical Trials Overview
        • Table LyoGo Pipeline Products & Ongoing Clinical Trials Overview
        • Table QuickStick - Product Status
        • Table QuickStick - Product Description
    • Meridian Medical Technologies Inc Company Overview
      • Meridian Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Meridian Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Midazolam Auto-Injector - Product Status
        • Table Midazolam Auto-Injector - Product Description
    • Mertiva AB Company Overview
      • Mertiva AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mertiva AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nerve Targeting Drug Delivery System - Product Status
        • Table Nerve Targeting Drug Delivery System - Product Description
    • Milestone Scientific Inc Company Overview
      • Milestone Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Milestone Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CompuFlo Epidural Computer Controlled Anesthesia System - Product Status
        • Table CompuFlo Epidural Computer Controlled Anesthesia System - Product Description
        • Table CompuFlo Intra-Articular Instrument - Product Status
        • Table CompuFlo Intra-Articular Instrument - Product Description
        • Table CompuFlo System - Cosmetic Surgery - Product Status
        • Table CompuFlo System - Cosmetic Surgery - Product Description
        • Table CompuFlo System - General Medical Injection - Product Status
        • Table CompuFlo System - General Medical Injection - Product Description
        • Table CompuFlo System - Ophthalmic Injection - Product Status
        • Table CompuFlo System - Ophthalmic Injection - Product Description
        • Table CompuFlo System - Peripheral Nerve Block - Product Status
        • Table CompuFlo System - Peripheral Nerve Block - Product Description
        • Table CompuFlo System - Self-Administered Drug Delivery - Product Status
        • Table CompuFlo System - Self-Administered Drug Delivery - Product Description
        • Table Milestone Scientific Inc - Ongoing Clinical Trials Overview
        • Table CompuFlo Epidural Computer Controlled Anesthesia System - Evaluation of the Compuflo Epidural Instrument for Thoracic Epidural Space Identification
    • Novo Nordisk AS Company Overview
      • Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novo Nordisk AS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ozempic Pen - Product Status
        • Table Ozempic Pen - Product Description
    • Novosanis NV Company Overview
      • Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novosanis NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table VAX-ID - Product Status
        • Table VAX-ID - Product Description
    • Osteo Pharma BV Company Overview
      • Osteo Pharma BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Osteo Pharma BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table OsteoActivator M - Product Status
        • Table OsteoActivator M - Product Description
    • Oval Medical Technologies Ltd Company Overview
      • Oval Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oval Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table EpiQ - Product Status
        • Table EpiQ - Product Description
    • Particle Therapeutics Ltd Company Overview
      • Particle Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Particle Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table PRT Glucagon Device - Product Status
        • Table PRT Glucagon Device - Product Description
    • Pfizer Inc Company Overview
      • Pfizer Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pfizer Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sayana Press - Self Administration - Product Status
        • Table Sayana Press - Self Administration - Product Description
    • Portal Instruments Inc Company Overview
      • Portal Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Portal Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PRIME - Product Status
        • Table PRIME - Product Description
    • pSivida Corp Company Overview
      • pSivida Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table pSivida Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Durasert - Back Of Eye Disease - Product Status
        • Table Durasert - Back Of Eye Disease - Product Description
        • Table Durasert - Front Of Eye Disease - Product Status
        • Table Durasert - Front Of Eye Disease - Product Description
        • Table Durasert - Knee Osteoarthritis - Product Status
        • Table Durasert - Knee Osteoarthritis - Product Description
        • Table Durasert - Posterior Segment Uveitis - Product Status
        • Table Durasert - Posterior Segment Uveitis - Product Description
        • Table Durasert Latanoprost Implant - Product Status
        • Table Durasert Latanoprost Implant - Product Description
        • Table DURASERT With TKI - Wet AMD - Product Status
        • Table DURASERT With TKI - Wet AMD - Product Description
        • Table Next Gen Duraset - Posterior Segment Uveitis - Product Status
        • Table Next Gen Duraset - Posterior Segment Uveitis - Product Description
        • Table Tethadur System - Product Status
        • Table Tethadur System - Product Description
        • Table pSivida Corp - Ongoing Clinical Trials Overview
        • Table Durasert - Knee Osteoarthritis - A Pilot Study of a Dexamethasone Implant System in Humans
        • Table Durasert - Posterior Segment Uveitis - A Multi-center, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal (FAI) Insert in Subjects with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye
        • Table Durasert - Posterior Segment Uveitis - A Phase III, Multi-national, Multi-center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects with Chronic Non-infectious Uveitis Affecting the Posterior Segment of the Eye
    • Queen Elizabeth Hospital Company Overview
      • Queen Elizabeth Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table Queen Elizabeth Hospital Pipeline Products & Ongoing Clinical Trials Overview
        • Table SAFIRA - Product Status
        • Table SAFIRA - Product Description
    • QuiO Technologies LLC Company Overview
      • QuiO Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table QuiO Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Si One - Product Status
        • Table Si One - Product Description
        • Table Si Pen - Product Status
        • Table Si Pen - Product Description
    • RepliCel Life Sciences Inc Company Overview
      • RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RepliCel Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RCI-02 Dermal Injector Device - Product Status
        • Table RCI-02 Dermal Injector Device - Product Description
    • Rescitech Vision Pvt Ltd Company Overview
      • Rescitech Vision Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rescitech Vision Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Safe Injection System - Product Status
        • Table Safe Injection System - Product Description
    • RetinaPharma Technologies Inc Company Overview
      • RetinaPharma Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RetinaPharma Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PhotoTarget Drug Delivery System - Product Status
        • Table PhotoTarget Drug Delivery System - Product Description
    • Roche Diagnostics International Ltd Company Overview
      • Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ranibizumab Port Delivery System (RPDS) - Product Status
        • Table Ranibizumab Port Delivery System (RPDS) - Product Description
        • Table Roche Diagnostics International Ltd - Ongoing Clinical Trials Overview
        • Table Ranibizumab Port Delivery System (RPDS) - A Phase II, Multicenter, Randomized, Active Treatment-controlled Study of the Efficacy and Safety of the Ranibizumab Port Delivery System for Sustained Delivery of Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
    • Scandinavian Health Ltd Company Overview
      • Scandinavian Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Scandinavian Health Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rotaject Auto-Injector Device - Product Status
        • Table Rotaject Auto-Injector Device - Product Description
    • Sun Pharma Advanced Research Company Ltd Company Overview
      • Sun Pharma Advanced Research Company Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sun Pharma Advanced Research Company Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Somatostatin Analogue Microspheres - Product Status
        • Table Somatostatin Analogue Microspheres - Product Description
    • TCB medical devices Company Overview
      • TCB medical devices Pipeline Products & Ongoing Clinical Trials Overview
        • Table TCB medical devices Pipeline Products & Ongoing Clinical Trials Overview
        • Table Epinephrine Auto-Injector Key - Product Status
        • Table Epinephrine Auto-Injector Key - Product Description
    • Terumo Corp Company Overview
      • Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Large Volume Injector - Product Status
        • Table Large Volume Injector - Product Description
        • Table PLAJEX With FKB327 - Product Status
        • Table PLAJEX With FKB327 - Product Description
        • Table PLAJEX With Tapered Needle - Product Status
        • Table PLAJEX With Tapered Needle - Product Description
    • Teva Pharmaceutical Industries Ltd Company Overview
      • Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BYETTA - Product Status
        • Table BYETTA - Product Description
        • Table Injectable Device - Product Status
        • Table Injectable Device - Product Description
    • TheraKine Inc (Inactive) Company Overview
      • TheraKine Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table TheraKine Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table AngioKine - Product Status
        • Table AngioKine - Product Description
    • Twin Star Medical Inc Company Overview
      • Twin Star Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Twin Star Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Porous Hollow Fiber Catheter - Product Status
        • Table Porous Hollow Fiber Catheter - Product Description
    • Unilife Corporation Company Overview
      • Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Unilife Corporation Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ocu-ject - Product Status
        • Table Ocu-ject - Product Description
        • Table Unifill Finesse - Product Status
        • Table Unifill Finesse - Product Description
        • Table Unifill Select - Product Status
        • Table Unifill Select - Product Description
        • Table Unilife Auto Injector - Product Status
        • Table Unilife Auto Injector - Product Description
    • University of Calgary Company Overview
      • University of Calgary Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Calgary Pipeline Products & Ongoing Clinical Trials Overview
        • Table Painless Drug Delivery Device - Product Status
        • Table Painless Drug Delivery Device - Product Description
    • University of California San Diego Company Overview
      • University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biodegradable Porous Silicon Contraceptive - Product Status
        • Table Biodegradable Porous Silicon Contraceptive - Product Description
        • Table Spinal Injection Device - Product Status
        • Table Spinal Injection Device - Product Description
    • University of California San Francisco Company Overview
      • University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery Cannula System - Product Status
        • Table Drug Delivery Cannula System - Product Description
    • University of Delaware Company Overview
      • University of Delaware Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Delaware Pipeline Products & Ongoing Clinical Trials Overview
        • Table Injectable Drug Delivery Device - Product Status
        • Table Injectable Drug Delivery Device - Product Description
    • University of Dundee Company Overview
      • University of Dundee Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Dundee Pipeline Products & Ongoing Clinical Trials Overview
        • Table Multipoint Injector - Product Status
        • Table Multipoint Injector - Product Description
    • University of Florida Company Overview
      • University of Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Florida Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomaterial Delivery System - Type 1 Diabetes - Product Status
        • Table Biomaterial Delivery System - Type 1 Diabetes - Product Description
        • Table MEMS Device - Product Status
        • Table MEMS Device - Product Description
    • University of Saskatchewan Company Overview
      • University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview
        • Table Auto-Injector System - Product Status
        • Table Auto-Injector System - Product Description
    • University of Texas at Austin Company Overview
      • University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nanofabricated Drug Delivery Device - Product Status
        • Table Nanofabricated Drug Delivery Device - Product Description
    • Vanderbilt University Company Overview
      • Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aliquot Delivery System - Product Status
        • Table Aliquot Delivery System - Product Description
    • West Pharmaceutical Services Inc Company Overview
      • West Pharmaceutical Services Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table West Pharmaceutical Services Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Next Generation Self-injection Device - Product Status
        • Table Next Generation Self-injection Device - Product Description
    • Windgap Medical Inc Company Overview
      • Windgap Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Windgap Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abiliject - Product Status
        • Table Abiliject - Product Description
    • XERIS Pharmaceuticals Inc Company Overview
      • XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table XERIS Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table DiazePen - Product Status
        • Table DiazePen - Product Description
    • Ypsomed Holding AG Company Overview
      • Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table YpsoDose - Product Status
        • Table YpsoDose - Product Description
  • Injectable Drug Delivery- Recent Developments
    • Mar 08, 2018: Adamis Pharmaceuticals Announces Publication of a New Human Factors Study Comparing Its Symjepi Epinephrine Prefilled Syringe to the Market Leading Product in the Annals of Allergy, Asthma and Immunology
    • Mar 06, 2018: Adamis Pharmaceuticals Provides Update on Data Presented at the American Academy of Allergy, Asthma and Immunology (AAAAI) Joint Congress With the World Allergy Organization
    • Mar 06, 2018: Sanofi's Board of Directors Proposes Appointment of Emmanuel Babeau as New Independent Director
    • Mar 06, 2018: Wendy Sussman Joins EMD Serono as Vice President of U.S. Healthcare Government & Public Affairs
    • Mar 05, 2018: Pfizer Names Dan R. Littman As Board Director
    • Mar 02, 2018: FDA to Review DUPIXENT (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
    • Mar 02, 2018: Clearside Biomedical Schedules Conference Call to Review Topline Results from Pivotal Phase 3 PEACHTREE Clinical Trial of CLS-TA in Macular Edema Associated with Non-Infectious Uveitis
    • Mar 01, 2018: Alkermes Names James Robinson as President and Chief Operating Officer
    • Feb 28, 2018: Mylan Reports Full Year and Fourth Quarter 2017 Results and Provides 2018 Guidance
    • Feb 28, 2018: Catalent Completes $4.6 Million Expansion at Singapore Facility
    • Feb 27, 2018: Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta (pegfilgrastim)
    • Feb 26, 2018: West Names Silji Abraham Chief Digital And Transformation Officer
    • Feb 26, 2018: 16-Year Veteran Director Wendy Cameron to Retire from Mylan Board after 2018 AGM
    • Feb 26, 2018: Recipharm: Chief Financial Officer to leave Recipharm
    • Feb 25, 2018: Dr. Reddy's Laboratories Provides Update on USFDA Audit of its API Manufacturing Plant at Srikakulam, India
    • Feb 23, 2018: Pfizer Appoints Albert Bourla As Board Director
    • Feb 22, 2018: Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2017 Financial Results
    • Feb 22, 2018: BioMarin Reports Fourth Quarter 2017 Financial Results
    • Feb 22, 2018: Recipharm Reports Fourth Quarter And Full Year 2017
    • Feb 21, 2018: United Therapeutics Reports 2017 Fourth Quarter And Annual Financial Results
    • Feb 21, 2018: Merck Invests Additional €40 Million to Enhance Manufacturing and Distribution in Asia
    • Feb 20, 2018: Halozyme Reports Fourth Quarter And Full-Year 2017 Results
    • Feb 20, 2018: Catalent Announces Changes to its Board of Directors
    • Feb 19, 2018: Dr Reddy's Laboratories: Update on US Lawsuit
    • Feb 15, 2018: West Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly Dividend
    • Feb 14, 2018: Antares Pharma Announces FDA Approval of Partners Product Utilizing Our QuickShot Auto Injector
    • Feb 14, 2018: Alkermes Names Shane Cooke As Board Director
    • Feb 14, 2018: Shire reports 8% pro forma product sales and strong earnings growth resulting in record operating cash flow for full year 2017
    • Feb 14, 2018: Recipharm Appoints President Development Services to Drive End to End Offering
    • Feb 14, 2018: Alkermes Reports Q4 2017 Financial Results
    • Feb 12, 2018: BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102
    • Feb 08, 2018: First targeted treatment for adults with moderate-to-severe atopic dermatitis, Dupixent, now available in Canada
    • Feb 08, 2018: Teva Reports 2017 Full Year and Fourth Quarter Financial Results
    • Feb 07, 2018: SelfDose Patient-Controlled Injector Named as Recipient of Pharmapack Exhibitor Innovation Award
    • Feb 07, 2018: Sanofi Delivers 2017 Business EPS in line with Guidance
    • Feb 07, 2018: pSivida Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines
    • Feb 06, 2018: BD Announces Results For 2018 First Fiscal Quarter; Provides Fiscal 2018 Guidance Updated For Inclusion Of Bard
    • Feb 06, 2018: Covestro plastic enables medical device innovation
    • Feb 06, 2018: MRI Interventions Announces Record 629 ClearPoint Cases in 2017
    • Feb 06, 2018: Teva Pharmaceuticals laid off 46 employees in Parsippany
    • Feb 05, 2018: Catalent Reports Second Quarter Fiscal 2018 Financial Results
    • Feb 02, 2018: Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe
    • Feb 02, 2018: AstraZeneca: Full-Year 2017 Results
    • Feb 02, 2018: Merck Announces Fourth-Quarter and Full-Year 2017 Financial Results
    • Feb 01, 2018: Novo Nordisk increased reported operating profit by 1% in 2017 to DKK 49 billion (5% growth in local currencies)
    • Jan 30, 2018: Pfizer Reports Fourth-Quarter And Full-Year 2017 Results
    • Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
    • Jan 26, 2018: Merck Appoints Dirk Toepfer as Chief Information Officer
    • Jan 25, 2018: Biogen Reports Revenues for Both the Full Year and Fourth Quarter of 2017
    • Jan 25, 2018: Dr. Reddy's Q3 and 9M FY18 Financial Results
    • Jan 24, 2018: Dr. Reddy's Laboratories: Intimation regard to Communication from Betapharm Arzneimittel, Germany from the Regulatory Authority of Germany
    • Jan 23, 2018: Shire Continues to Uphold High Standards of Ethics and Transparency with Adoption of Open Access Policy for Publication of Shire-Supported Research
    • Jan 19, 2018: Shire: Directorate Change
    • Jan 19, 2018: Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee
    • Jan 19, 2018: Teva Layoffs To Affect 65 Employees In Horsham, North Wales
    • Jan 18, 2018: B. Braun to Showcase Comprehensive Parenteral Nutrition Program, New Compounder and More at ASPEN
    • Jan 12, 2018: Repatha SC Injection 420 mg Auto Mini Doser Launched in Japan
    • Jan 11, 2018: More than 5000 Lives Reported Saved with Help of EVZIO (naloxone HCl injection) Auto-injectors
    • Jan 10, 2018: BYDUREON BCise Injectable Medicine Now Available In The US For Patients With Type-2 Diabetes
    • Jan 10, 2018: Delcath Announces Special Protocol Agreement Modification With FDA
    • Jan 09, 2018: Midatech receives confirmation that its Q-Octreotide (MTD201) first inhuman EU study is approved
    • Jan 09, 2018: Positive Results From a Multi-Center Analysis of Delcath PHP Therapy Published in Journal of Surgical Oncology
    • Jan 09, 2018: Halozyme Projects 25 To 30 Percent ENHANZE Royalty Growth In 2018
    • Jan 08, 2018: pSivida Submits New Drug Application (NDA) for Durasert Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA
    • Jan 08, 2018: pSivida Submits New Drug Application for Durasert Three-Year Treatment for Posterior Segment Uveitis to the U.S. FDA
    • Jan 08, 2018: Emergent BioSolutions Announces Preliminary 2017 Financial Results and Provides 2018 Financial Outlook
    • Jan 08, 2018: Common Sensing Announces Kevin Schmid as Chief Operating Officer
    • Jan 05, 2018: BioCorRx Retains Regulatory Drug Expert Priya Jambhekar and CMC Expert Bruce Firestone
    • Jan 04, 2018: pSivida Granted Waiver by the FDA for New Drug Application Filing Fee
    • Jan 04, 2018: Generex CEO Provides 2017 Year-End Summary to Stakeholders
    • Jan 02, 2018: Midatech enters into a Loan Agreement with MidCap Financial
    • Jan 02, 2018: Shire: Director Declaration
    • Dec 30, 2017: Connect with SHL at Drug Delivery Partnerships 2018
    • Dec 27, 2017: Shire files for FDA approval of a new plasma manufacturing facility in Covington, Georgia to support growing Immunology franchise
    • Dec 21, 2017: First cohort dosed in Phase 1 clinical study of sustained release treprostinil injection for treatment of PAH
    • Dec 21, 2017: Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit
    • Dec 20, 2017: New Patent Issued to AMAG Pharmaceuticals Entitled "Methods of Reducing Risk of Preterm Birth"
    • Dec 20, 2017: Milestone Scientific Provides Year-End Recap of Key Developments
    • Dec 20, 2017: Ulrich Faessler appointed CEO of SHL Medical
    • Dec 19, 2017: Bob White Named Executive Vice President and President of Medtronic's Minimally Invasive Therapies Group; Chris Lee to Assume Leadership of Medtronic's Asia Pacific Region
    • Dec 19, 2017: Shire:Director Declaration
    • Dec 18, 2017: Leonard Osser to Re-Assume Role as CEO of Milestone Scientific
    • Dec 15, 2017: Petra Wicklandt Appointed Head of Corporate Affairs at Merck
    • Dec 14, 2017: HSS and pSivida Report Positive Phase 1 Knee Osteoarthritis Pain Study Data
    • Dec 14, 2017: Needle-free injection device moves closer to market
    • Dec 14, 2017: Teva Announces Restructuring Plan and Additional Measures to Improve Its Business and Financial Performance
    • Dec 12, 2017: Allan Gabor Takes Over the Leadership of Merck in China
    • Dec 12, 2017: Milestone Scientific Participates in the 2017 Greater New York Dental Meeting
    • Dec 08, 2017: Chief Financial Officer update
    • Dec 08, 2017: Shire: Chief Financial Officer update
    • Dec 06, 2017: Merck: Resignation of Managing Director
    • Dec 05, 2017: Novo Nordisk: Ozempic (Semaglutide) Approved In The US
    • Dec 05, 2017: Consort Medical: Interim results
    • Dec 04, 2017: Biogen Appoints Mark Hernon as SVP, Chief Information Officer
    • Dec 01, 2017: Adamis Pharmaceuticals Announces Presentation of a Human Factors Study Results for Symjepi at the AAAAI Joint Congress With the World Allergy Organization
    • Dec 01, 2017: Shire Appoints Andreas Busch, Ph D as Head of Research and Development and Chief Scientific Officer
    • Dec 01, 2017: Dr. Reddy's Laboratories: Intimation regard to the US FDA audit
    • Nov 29, 2017: Adamis Pharmaceuticals Submits Prior Approval Supplement to FDA for the Pediatric Version of Symjepi
    • Nov 27, 2017: Teva Announces New Organization Structure and Leadership Changes
    • Nov 22, 2017: Milestone unveils cosmetic injection instrument for Botox
    • Nov 21, 2017: Biogen Appoints Jeff Capello as Executive Vice President and Chief Financial Officer
    • Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
    • Nov 20, 2017: U.S. FDA Approves Kaléo's AUVI-Q (Epinephrine Injection, USP) 0.1 mg Auto-Injector for Life-Threatening Allergic Reactions in Infants and Small Children
    • Nov 20, 2017: Milestone Scientific Announces Planned Launch of Instrument for Botox Delivery
    • Nov 20, 2017: Shire to Appoint Thomas Dittrich as Chief Financial Officer and Member of the Board of Directors
    • Nov 17, 2017: Amgen Launches The ENBREL Mini Single-Dose Prefilled Cartridge With AutoTouch Reusable Autoinjector That Is Ergonomically Designed For Patients
    • Nov 15, 2017: BioCorRx Enters Confidentiality Agreement with Federal Government Research Institute; Plans to Attend FDA Meeting for Naltrexone Implant
    • Nov 15, 2017: Milestone Scientific Reports Ten-Fold Increase in Domestic Dental Sales for the Third Quarter of 2017
    • Nov 15, 2017: Heiko Schipper is the new CEO and Head of the Consumer Health Division at Bayer
    • Nov 14, 2017: Results of New Clinical Study Show Epidural Space Correctly Identified in 100% of Labor & Delivery Patients Using Milestone Scientific's CompuFlo Epidural Instrument
    • Nov 14, 2017: Albireo Reports Third Quarter 2017 Financial Results
    • Nov 14, 2017: Delcath Announces Third Quarter 2017 Financial Results
    • Nov 14, 2017: Organizational changes in quality management at Haselmeier: Mr. Konrad Betzler becomes new CQO (Chief Quality Officer)
    • Nov 14, 2017: Pfizer is looking to fill 200 new positions in Portage
    • Nov 13, 2017: Merck Receives FDA Approval for New GONAL-f Prefilled Pen
    • Nov 13, 2017: Pfizer Names Albert Bourla Chief Operating Officer
    • Nov 10, 2017: Mylan Announces Voluntary Delisting from the Tel Aviv Stock Exchange
    • Nov 09, 2017: Recipharm to end operations in two facilities in Sweden
    • Nov 09, 2017: Merck Confirms Outlook for 2017 Despite a Challenging Third Quarter
    • Nov 09, 2017: AstraZeneca Announces Year-To-Date and Q3 2017 Results
    • Nov 09, 2017: Ypsomed Grows during First half-year and Raises its Forecast for the Year
    • Nov 09, 2017: Vetter Expands its Footprint in Asia Pacific Region
    • Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
    • Nov 08, 2017: Clearside Biomedical Announces Third Quarter 2017 Financial Results and Provides Corporate Update
    • Nov 07, 2017: Key Opinion Leader Reports 100% Success Rate in more than 150 Procedures Using Milestone Scientific's CompuFlo Epidural System
    • Nov 07, 2017: pSivida Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution
    • Nov 07, 2017: Antares Pharma Reports Third Quarter 2017 Operating and Financial Results
    • Nov 07, 2017: Halozyme Reports Third Quarter 2017 Results
    • Nov 06, 2017: West to Showcase New Extensions of the SmartDose Drug Delivery Platform at the PDA Universe of Pre-filled Syringes and Injection Devices
    • Nov 06, 2017: BTG: Varithena receives finalised category I CPT codes
    • Nov 06, 2017: Mylan Reports Third Quarter 2017 Results and Updates 2017 Guidance
    • Nov 06, 2017: MRI Interventions Reports 26% Year-Over-Year Increase in Third Quarter Procedures
    • Nov 06, 2017: Catalent Reports First Quarter Fiscal 2018 Results
    • Nov 02, 2017: Emergent BioSolutions Reports Third Quarter and Nine Months 2017 Financial Results; Raises Calendar Year 2017 Guidance
    • Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
    • Nov 02, 2017: Biogen Appoints Chirfi Guindo as Executive Vice President and Head of Global Marketing, Market Access and Customer Innovation
    • Nov 02, 2017: Sanofi: Q3 2017 Business EPS up 1.1% at CER FY 2017 Guidance Confirmed
    • Nov 02, 2017: Teva Reports Third Quarter 2017 Financial Results
    • Nov 01, 2017: Novo Nordisk increased reported operating profit by 5% in the first nine months of 2017
    • Oct 31, 2017: Pfizer Reports Third-Quarter 2017 Results
    • Oct 31, 2017: Mylan Provides Statement in Response to Announcement of Proposed Amendments to Civil Complaint
    • Oct 31, 2017: Dr. Reddy's Q2 and H1 FY18 Financial Results
    • Oct 30, 2017: Kare Schultz to Join Teva as President and Chief Executive Officer
    • Oct 30, 2017: Dr Reddys Laboratories appoints Prasad R Menon as an Additional Director
    • Oct 27, 2017: Mylan's EpiPen4Schools Program Surpasses One Million Free Epinephrine Auto-Injector Donations to U.S. Schools
    • Oct 27, 2017: Shire Reports Strong Earnings Growth in Q3 2017; Reiterates Full Year Guidance
    • Oct 26, 2017: BioMarin Announces Third Quarter 2017 Financial Results
    • Oct 26, 2017: West Announces Third-Quarter 2017 Results
    • Oct 25, 2017: United Therapeutics Reports Third Quarter 2017 Financial Results
    • Oct 25, 2017: Cellnovo Reports Q3 Sales and Cash Position at September 30, 2017
    • Oct 24, 2017: Biogen Reports Quarterly Revenues of $3.1 Billion
    • Oct 23, 2017: US FDA approves new easy-to-use, once-weekly Bydureon BCise injectable medicine for patients with type-2 diabetes
    • Oct 23, 2017: Recipharm equips Lisbon facility for US and European serialisation
    • Oct 23, 2017: EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
    • Oct 17, 2017: Bayer Appoints Brenda L. Raphael Senior Vice President and General Manager of Therapeutics Business Unit for Consumer Health
    • Oct 12, 2017: CAPS to Showcase Latest 503B Quality Assurance Capabilities and Expansion Plans at Health Connect Reverse Expo - Fall Hospital Pharmacy Conference
    • Oct 11, 2017: Milestone Scientific Announces over 500 Successful Procedures Using CompuFlo Epidural System
    • Oct 10, 2017: Study Demonstrates Benefit of West's ID Adapter for Improving Intradermal Administration of Polio Vaccine
    • Oct 09, 2017: Guerbet to Take Part in the 65th Edition of the Francophone Days of Diagnostic and Interventional Radiology (JFR)
    • Oct 09, 2017: Anaphylaxis and the Importance of Always Having an EpiPen
    • Oct 09, 2017: MRI Interventions Announces Joseph Burnett As New President and CEO
    • Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
    • Oct 05, 2017: Milestone Scientific Announces Appointment of Leslie Bernhard as Interim CEO
    • Oct 04, 2017: Emergent BioSolutions Awarded U.S. Department of State Contract Valued at Up to $25 Million to Supply Nerve Agent Antidote Auto-Injector
    • Oct 03, 2017: Pharmaceutical Company Mylan to Pay $20.3 Million for Underpaying Rebates on Epipens for Masshealth Members
    • Oct 03, 2017: BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors
    • Oct 02, 2017: Emergent BioSolutions Announces Closing of New $200 Million Senior Secured Credit Facility
    • Oct 01, 2017: Molnlycke to establish R&D innovation unit in AstraZeneca's BioVentureHub
    • Sep 28, 2017: BioCorRx Announces Update on Commercialization Efforts for Naltrexone Implant
    • Sep 28, 2017: Midatech Pharma: Interim results for the six months ended 30 June 2017
    • Sep 28, 2017: Merck On Course To Achieve Objectives for 2018
    • Sep 28, 2017: Albireo Elects Roger Jeffs to Board of Directors
    • Sep 21, 2017: Fresenius Kabi breaks ground for $250 million manufacturing campus in Chicago
    • Sep 21, 2017: Dr. Reddy's Laboratories: Intimation about audit of Srikakulam Plant Unit II, Andhra Pradesh, by the US FDA
    • Sep 20, 2017: Milestone Scientific's CompuFlo Epidural Instrument Featured in Abstract Presented at the 36th Annual Congress of The European Society of Regional Anaesthesia & Pain Therapy
    • Sep 19, 2017: Teva Completes Amendment to Credit Facilities
    • Sep 15, 2017: Dr. Reddy's Laboratories: Intimation about audit of API Mirfield Plant, United Kingdom, by the US FDA
    • Sep 14, 2017: Guerbet Announces CE Mark for Vectorio, An Innovative Medical Device for cTACE Procedures
    • Sep 14, 2017: Delcath Announces Accelerated Listing on OTCQB
    • Sep 13, 2017: RepliCel's Partnership Initiatives Mature into Licensing Negotiations
    • Sep 13, 2017: Mylan Names Dennis Zeleny as Chief Human Relations Officer
    • Sep 13, 2017: Delcath Announces Relisting on OTCQB
    • Sep 12, 2017: Nearly $7M in EpiPen Settlement Funding Headed to Louisiana
    • Sep 12, 2017: Biogen Appoints Sanjay Jariwala as SVP, Worldwide Medical
    • Sep 11, 2017: Teva Names Kare Schultz as President and Chief Executive Officer
    • Sep 11, 2017: Merck Names Heidi Fagerholm as New Head of Advanced Technologies
    • Sep 11, 2017: pSivida Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 Results
    • Sep 08, 2017: Mylan Statement on Warning Letter Issued to Pfizer's EpiPen Auto- Injector Manufacturing Site
    • Sep 08, 2017: Dr. Reddy's Laboratories: Regulatory Authority of Germany concludes audit of Formulations manufacturing facility in Vishakapatnam, India
    • Sep 08, 2017: Dr. Reddy's Laboratories Announces Intimation on audit
    • Sep 07, 2017: RepliCel Showcases First Fully-Functional Prototypes of its Next- Generation Dermal Injector
    • Sep 05, 2017: Astrazeneca Appoints Sheri Mccoy and Deborah Disanzo to its Board
    • Sep 05, 2017: Forward Pharma Files Opening Brief in the Appeal of the U.S. Patent Interference to the Federal Circuit
    • Sep 05, 2017: Merck Prepares Strategic Options for the Consumer Health Business
    • Sep 01, 2017: Kaleo Donates Thousands of EVZIO (naloxone HCl injection) Autoinjectors to Hurricane Harvey Relief Efforts
    • Sep 01, 2017: Kaleo Donates Thousands of AUVI-Q (epinephrine injection, USP) Autoinjectors to Hurricane Harvey Relief Efforts
    • Aug 31, 2017: Aquavit Pharmaceuticals Adds New Patent to its High-Tech Medical Portfolio
    • Aug 30, 2017: Repatha Receives Approval for New 420mg Single-Dose Delivery Option in Japan
    • Aug 29, 2017: Delcath Announces Medical University of Hannover in Germany Celebrates 100th CHEMOSAT Treatment
    • Aug 29, 2017: Sandoz Invests in Major Expansion of Global Headquarters in Holzkirchen, Germany
    • Aug 28, 2017: Catalent Reports Fourth Quarter and Full Year 2017 Results
    • Aug 22, 2017: Medtronic Reports First Quarter Financial Results
    • Aug 21, 2017: Shire Director and Senior Management Changes
    • Aug 21, 2017: Albireo Reports Second Quarter 2017 Financial Results
    • Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson
    • Aug 17, 2017: Mylan Finalizes Settlement Agreement on Medicaid Rebate Classification for EpiPen Auto-Injector
    • Aug 17, 2017: Mylan Agrees to Pay $465 Million to Resolve False Claims Act Liability for Underpaying EpiPen Rebates
    • Aug 16, 2017: Astrazeneca Non-executive Director Retirement
    • Aug 15, 2017: Changes in Novo Nordisk Executive Management
    • Aug 14, 2017: Milestone Scientific Provides Business Update for the Second Quarter of 2017
    • Aug 09, 2017: Novo Nordisk increased reported operating profit by 8% in the first six months of 2017
    • Aug 09, 2017: Clearside Biomedical Announces Second Quarter 2017 Financial Results and Provides Corporate Update
    • Aug 09, 2017: Mylan Reports Second Quarter 2017 Results and Updates 2017 Guidance
    • Aug 08, 2017: Milestone Scientific Announces First Patient Treated with CompuFlo Epidural Instrument at University of Miami Hospital
    • Aug 08, 2017: Delcath Announces Second Quarter 2017 Financial Results
    • Aug 08, 2017: Clearside Biomedical Announces Changes to its Board of Directors
    • Aug 08, 2017: Halozyme Reports Second Quarter 2017 Results
    • Aug 08, 2017: Antares Pharma Reports Second Quarter 2017 Operating And Financial Results
    • Aug 07, 2017: Kaleo Announces AUVI-Q (epinephrine injection, USP) Charitable Donation Program for All Public Elementary Schools in the United States
    • Aug 03, 2017: Q2 2017: Merck Sets Course for Future Growth
    • Aug 03, 2017: Executive Board Changes at Merck
    • Aug 03, 2017: Emergent BioSolutions Reports Second Quarter and Six Months 2017 Financial Results; Reaffirms Calendar Year 2017 Guidance
    • Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter
    • Aug 03, 2017: Shire reports strong Q2 2017 operating results and cash flow; updates full year guidance
    • Aug 03, 2017: Teva Reports Second Quarter 2017 Financial Results
    • Aug 03, 2017: Aratana Therapeutics Reports Second Quarter 2017 Financial Results
    • Aug 02, 2017: SAMHSA announces $6 million in grants to support the International President's Emergency Plan for AIDS Relief Addiction Technology Transfer Centers
    • Aug 02, 2017: BioMarin Announces Second Quarter 2017 Financial Results
    • Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results
    • Aug 01, 2017: MRI Interventions Reports 79% Revenue Increase and Record Treatments in Second Quarter 2017
    • Jul 31, 2017: Sanofi Raises FY 2017 Business EPS Guidance to Broadly Stable at CER
    • Jul 31, 2017: Biogen Appoints Anabella Villalobos Senior Vice President, Biotherapeutic & Medicinal Sciences
    • Jul 31, 2017: Emergent BioSolutions Awarded $23 Million to Develop Novel Multi-Drug Auto-Injector for U.S. Department of Defense
    • Jul 31, 2017: Connect with SHL at BIO International Convention 2017
    • Jul 31, 2017: AstraZeneca and MedImmune strengthen immuno-oncology leadership with appointment of two renowned experts31 July 2017
    • Jul 28, 2017: Milestone Scientific Launches New User-Friendly, Multi-Platform Compatible Website
    • Jul 27, 2017: U.S. FDA Grants Priority Review for an Epinephrine Auto-Injector in Development by Kaleo Specifically for Infants and Small Children
    • Jul 27, 2017: Aquavit Pharmaceuticals Granted Patent for Apollo (PITO-001): System & Method for Personalized Injection Treatment in European Union
    • Jul 27, 2017: AstraZeneca Announce H1 2017 Results
    • Jul 27, 2017: Alkermes Reports Second Quarter 2017 Financial Results
    • Jul 27, 2017: Dr. Reddy's Q1 FY18 Financial Results
    • Jul 27, 2017: West Announces Second-Quarter 2017 Results
    • Jul 27, 2017: United Therapeutics Reports Second Quarter 2017 Financial Results
    • Jul 26, 2017: Catalent Applied Drug Delivery Institute Appoints Jim Spavins To Advisory Board
    • Jul 25, 2017: Vancouver's EVA Vein Care Now Offers New Varicose Vein Treatment
    • Jul 25, 2017: BioCorRx Announces EnLite Clinics to Implement the BioCorRx Recovery Program in Three Clinics in Ohio
    • Jul 25, 2017: Biogen Reports Record Quarterly Revenues of $3.1 Billion, Raises Full Year Revenue Guidance
    • Jul 24, 2017: Alisha A. Alaimo Appointed SVP of Biogen's US Therapeutic Operations
    • Jul 23, 2017: Teva to Terminate Around 300 jobs in Israel
    • Jul 21, 2017: Dr. Reddy's Laboratories: Update On US FDA Audit at API Cuernavaca Plant
    • Jul 21, 2017: Merck Opens New Application Laboratory in Shanghai
    • Jul 18, 2017: Leading Retinal Specialists to Highlight pSivida's Durasert for Treatment of Posterior Segment Uveitis at Prestigious Ophthalmology Conferences
    • Jul 13, 2017: Teva Enhances Board of Directors as All Proposals Approved at Annual General Meeting of Shareholders
    • Jul 12, 2017: Merck Refines Western European Life Science Production Site Network
    • Jul 12, 2017: Sanofi: Pre-quarterly Results Communication
    • Jul 11, 2017: Portal Instruments Appoints Wendy Dwyer as Chief Business Officer
    • Jul 11, 2017: Milestone Scientific Appoints Daniel Goldberger as CEO to Lead Transition to a Commercially Focused Global Medical Device Company
    • Jul 11, 2017: MRI Interventions Announces Record Second Quarter ClearPoint System Procedures, And a 79% Year-Over-Year Revenue Increase
    • Jul 10, 2017: Biogen Appoints Amy Chevalier Efantis Vice President of Government Affairs
    • Jun 29, 2017: Merck Expands Packaging Capacity at Swiss Biotech Manufacturing Site of Aubonne
    • Jun 29, 2017: Astra Zeneca: Outcome of the meeting of board of directors held on June 29, 2017
    • Jun 28, 2017: Phase 1 Clinical Trial Shows Safety and Immunogenicity of Microneedle Patch for Flu Vaccination for the First Time
    • Jun 28, 2017: Pfizer breaks ground on new R&D facility in Missouri
    • Jun 28, 2017: Biogen Appoints Catherine Steele Senior Vice President of Corporate Affairs
    • Jun 28, 2017: pSivida Enhances Board of Directors with Election of Veteran Healthcare Executive Kristine Peterson
    • Jun 27, 2017: Rhythm and Camurus Announce Positive Initial Data for Extended- Release Delivery of Setmelanotide for the Treatment of Rare Genetic Disorders of Obesity
    • Jun 27, 2017: Pfizer Breaks Ground on New R&D Facility in Chesterfield, Missouri
    • Jun 26, 2017: AMAG Announces U.S. FDA Filing Acceptance of Supplemental New Drug Application for Makena (hydroxyprogesterone caproate injection) Subcutaneous Auto-Injector
    • Jun 23, 2017: Milestone Scientific's FDA Cleared CompuFlo Featured on the Doctor's Channel in Segment Entitled: Demise of the Traditional Syringe and Rise of the Smart Syringe System
    • Jun 22, 2017: pSivida Submits Marketing Authorization Application for Approval of Durasert Three-year Treatment for Posterior Segment Uveitis in the European Union
    • Jun 22, 2017: Kaleo Donates 250,000th EVZIO (naloxone HCl injection) Auto-injector to Help Fight Opioid Overdose Epidemic
    • Jun 20, 2017: Enable Injections launches multi-vial/multi-syringe biologics delivery system
    • Jun 20, 2017: Biogen Appoints Ginger Gregory Executive Vice President, Chief Human Resources Officer
    • Jun 20, 2017: Merck Ventures Creates New Immuno-Oncology Company iOnctura
    • Jun 16, 2017: Dr. Reddy's Laboratories: Update on USFDA Audit
    • Jun 15, 2017: Adamis Pharmaceuticals Receives FDA Approval for Its Epinephrine Pre-Filled Syringe
    • Jun 15, 2017: Consort Medical: Full year results
    • Jun 14, 2017: Dr. Reddy's Provides Update on API manufacturing plant at Miryalaguda
    • Jun 14, 2017: Jean-Paul Kress Appointed EVP and President, International and Head of Global Therapeutic Operations
    • Jun 13, 2017: pSivida's Durasert Three-year Treatment for Posterior Segment Uveitis Successfully Achieves Primary Efficacy Endpoint in Second Phase 3 Study
    • Jun 13, 2017: Aquavit Pharmaceuticals Granted Patent for Apollo (PITO-001): System & Method for Personalized Injection Treatment by the USPTO
    • Jun 13, 2017: Biogen Announces Management Change
    • Jun 12, 2017: Milestone Scientific Announces 510(k) FDA Clearance for CompuFlo Epidural Instrument
    • Jun 06, 2017: BD Releases 2016 Sustainability Report
    • Jun 01, 2017: West Elects New Director to the Board
    • May 31, 2017: AstraZeneca appoints Professor Nazneen Rahman to its Board of Directors and Science Committee
    • May 30, 2017: Alkermes Appoints Craig Hopkinson, M.D., as Chief Medical Officer, and Senior Vice President, Clinical Development and Medical Affairs
    • May 30, 2017: West to Present on Biologics Trends at InnoPack Pharma Confex
    • May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
    • May 25, 2017: RepliCel CEO Provides Company Outlook
    • May 25, 2017: Dr. Reddy's Laboratories Provides Update on Srikakulum Plant
    • May 24, 2017: Ypsomed accelerates growth significantly
    • May 23, 2017: Terumo Announces European Medicines Agency Validates Marketing Authorization Application for a Biosimilar to Be Formulated by Terumo
    • May 18, 2017: Milestone Scientific Hosts Webcast with Top Key Opinion Leader to Discuss Advantages of the CompuFlo Epidural Instrument
    • May 18, 2017: Merck Continues to Grow Profitably in the First Quarter
    • May 17, 2017: Portal Instruments Marks Milestone, Publishing Results of Study in Peer-Reviewed Article in AAPS PharmSciTech
    • May 16, 2017: Antares Pharma Announces Poster Presentation at the American Urological Association Annual Meeting
    • May 16, 2017: Merck: Optimizing the Further Development of the Darmstadt Site
    • May 16, 2017: Change in composition of the Board of Directors of Novo Nordisk
    • May 15, 2017: Milestone Scientific Reports 53% Increase in Handpiece Sales Attributable to USA and Canada for the First Quarter of 2017
    • May 12, 2017: Constantin Birnstiel to Become Head of Group Communications at Merck
    • May 12, 2017: Dr. Reddy's Q4 and FY17 Financial Results
    • May 11, 2017: Healthcare Veteran John Fletcher Joins MRI Interventions' Board of Directors
    • May 11, 2017: Teva Reports First Quarter 2017 Financial Results
    • May 10, 2017: European Commission Grants Approval for Merck's New Pergoveris Pen for Fertility Treatment
    • May 10, 2017: Clearside Biomedical Announces First Quarter 2017 Financial Results and Provides Corporate Update
    • May 10, 2017: Mylan Reports First Quarter 2017 Results
    • May 10, 2017: Albireo Reports First Quarter 2017 Financial Results
    • May 10, 2017: Emergent BioSolutions Unveils Its Expanded Center for Innovation in Advanced Development and Manufacturing in Baltimore
    • May 10, 2017: Ypsomed expands to more countries
    • May 09, 2017: Delcath Announces First Quarter 2017 Financial Results
    • May 09, 2017: Antares Pharma Reports First Quarter 2017 Operating and Financial Results
    • May 09, 2017: Halozyme Reports First Quarter 2017 Financial Results
    • May 08, 2017: Durasert Three-year Treatment for Posterior Segment Uveitis Significantly Reduces Recurrences Through 12 Months
    • May 04, 2017: pSivida Provides Update On Durasert
    • May 04, 2017: pSivida Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track
    • May 04, 2017: Emergent BioSolutions Reports First Quarter 2017 Financial Results; Reaffirms 2017 Guidance
    • May 04, 2017: Catalent Reports Third Quarter Fiscal Year 2017 Results
    • May 04, 2017: pSivida Reports Fiscal 2017 Third Quarter Results
    • May 04, 2017: BioMarin Announces First Quarter 2017 Financial Results
    • May 03, 2017: Novo Nordisk increased reported operating profit by 10% in the first three months of 2017
    • May 03, 2017: West Highlights Company Scientific and Regulatory Expertise at Notable Industry Meetings
    • May 02, 2017: Shire delivers strong Q1 2017 revenue growth while advancing latestage pipeline
    • May 02, 2017: BD Announces Results For 2017 Second Fiscal Quarter
    • May 02, 2017: Pfizer Reports First-Quarter 2017 Results
    • May 01, 2017: Mylan Nominates Sjoerd Vollebregt for Election to Board of Directors
    • May 01, 2017: Forward Pharma Further Aligns Cost Structure with Focus Following Settlement and License Agreement
    • Apr 30, 2017: Scandinavian Health: Article on Rotaject Technology Featured in World Pharmaceutical Frontiers
    • Apr 30, 2017: Connect with SHL at Prefilled Syringe Seminar 2017 Tokyo
    • Apr 28, 2017: Sanofi Delivers Robust Q1 2017 Financial Results
    • Apr 27, 2017: AstraZeneca Announces Q1 2017 Results
    • Apr 27, 2017: Shire opens new HQ office in Dublin City Centre
    • Apr 27, 2017: West Announces First-Quarter 2017 Results
    • Apr 27, 2017: MRI Interventions Announces 2017 First Quarter Results
    • Apr 27, 2017: Alkermes Reports First Quarter 2017 Financial Results
    • Apr 26, 2017: UCB receives positive CHMP opinion for CIMZIA (certolizumab pegol) dose dispenser cartridge for use with ava electronic injection device
    • Apr 26, 2017: Teva Announces Planned Departure of Eyal Desheh, Group Executive Vice President and Chief Financial Officer
    • Apr 26, 2017: United Therapeutics Reports First Quarter 2017 Financial Results
    • Apr 25, 2017: United States Patent Issued to RepliCel for its Novel Dermal Injection Technologies
    • Apr 25, 2017: Biogen Reports First Quarter 2017 Revenues of $2.8 Billion
    • Apr 25, 2017: AstraZeneca marks a key milestone with the `topping out' of new global R&D centre and HQ in Cambridge, UK
    • Apr 24, 2017: Portal Instruments Receives ISO 13485:2012 Certification from NSAI
    • Apr 23, 2017: BD Announces Appointment Of Tom Polen As President
    • Apr 20, 2017: Merck Provides Upgraded Manufacturing Capabilities to BioInvent with Single-use Mobius Bioreactors
    • Apr 19, 2017: Milestone Scientific Announces Regulatory Marketing Clearance to Sell Epidural Instruments and Disposables in Saudi Arabia
    • Apr 18, 2017: Spire Southampton Hospital in UK Celebrating Over 100 CHEMOSAT Treatments
    • Apr 17, 2017: AMAG Submits Supplemental New Drug Application to FDA for Makena (Hydroxyprogesterone Caproate Injection) Auto-Injector for Subcutaneous Use
    • Apr 14, 2017: Dr. Reddy's Provides Update on USFDA Audit
    • Apr 13, 2017: Fresenius Kabi Files Amicus Brief in Arkansas
    • Apr 12, 2017: Unilife Files for Chapter 11 Protection
    • Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia
    • Apr 11, 2017: Sanofi Announces Pre-quarterly Results Communication
    • Apr 11, 2017: Major Novartis investment in Slovenia reinforces commitment to largest Sandoz product and business
    • Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter
    • Apr 05, 2017: Sanofi Appoints Bill Sibold Executive Vice President Sanofi Genzyme and Member of the Executive Committee
    • Apr 04, 2017: Milestone Scientific Announces Regulatory Marketing Clearance to Sell Epidural Instruments and Disposables in Australia
    • Apr 04, 2017: Milestone Scientific Announces Regulatory Marketing Clearance to Sell Intra-Articular Instruments and Disposables in Australia
    • Apr 04, 2017: Midatech Pharma Announces Audited financial results for the year ended 31 December 2016
    • Apr 03, 2017: Antares Pharma Announces Poster Presentation of Quickshot Testosterone Data at the Endocrine Society Annual Meeting
    • Apr 03, 2017: Milestone Scientific Reports 10% Increase in Revenue for Fiscal 2016
    • Apr 03, 2017: Dr. Reddy's Laboratories Provides Update on USFDA Inspection at Srikakulam plant
    • Mar 31, 2017: FDA alerts consumers of nationwide voluntary recall of EpiPen
    • Mar 31, 2017: FDA alerts consumers of nationwide voluntary recall of EpiPen Jr
    • Mar 31, 2017: First Collaborative Definition of Patient Centricity, Co-created by AstraZeneca with Patients and Carers, Is Published in British Medical Journal
    • Mar 30, 2017: SHL to Present at Pharmapack Symposium Taiwan 2017
    • Mar 29, 2017: Delcath Announces 2016 Financial Results
    • Mar 28, 2017: Vetter's Dr. Claudia Roth is appointed to the Fraunhofer Advisory Board
    • Mar 28, 2017: Mylan Names Former SEC Commissioner Daniel Gallagher as Chief Legal Officer
    • Mar 28, 2017: BD Announces Success of Helping Build Healthy Communities Program, Launches New Effort Focused on Medication Therapy Management
    • Mar 27, 2017: Delcath Announces Special Protocol Assessment Agreement With FDA for Pivotal Trial With Melphalan/HDS in Intrahepatic Cholangiocarcinoma
    • Mar 22, 2017: EMD Serono to Present Real-World Data Analyses at the Annual Pacific Coast Reproductive Society Meeting
    • Mar 21, 2017: Retractable Technologies Announces Litigation Updates
    • Mar 21, 2017: Merck Accelerator Hits New Peak of Applications
    • Mar 21, 2017: Catalent Biologics Announces The Appointment Of Matthew Stober To Advisory Board
    • Mar 20, 2017: Alphapharm Initiates Recall of EpiPen Auto-Injector in Australia
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report